Abstract
Troubling blind spots in understanding cancer risks among transgender patients: Bias, discrimination, and a lack of good data may be impeding cancer screening and risk assessments for the transgender population. In this article, the second of a 2-part series, we explore the remaining gaps in understanding and communicating the risks.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
